In conclusion, ICAM2 expression may be associated with radioresistance in OSCC cells, ICAM2 siRNA may enhance the radiosensitivity of oral cancer cells, and ICAM2 may be an effective radiotherapeutic target of oral cancer and a marker for radiation sensitivity based on in vitro studies with microarray analysis. This evidence concerns the gene ICAM2 and lip and oral cavity carcinoma.